Mustafa ALTINTAŞ, Gülsüm AKDENİZ, Bilgehan GÜRBÜZ, Yusuf Ali KARA, Osman CELBİŞ

Demographic and clinical features of Covid-19 cases in Serik, Turkey

There is a need for new research on the Covid-19 outbreak that affects the whole world. This study is presented as the first in a series of cases exist in Turkey. Our aim was to investigate the demographic and clinical features of Covid-19 patients and contribute to the development of new strategies. The medical records of 56 patients diagnosed with Covid-19 in Serik State Hospital, a pandemic hospital in Turkey, have been retrospectively evaluated up until May 31, 2020. The demographic and clinical characteristics as well as radiological and laboratory data of the patients were followed up until June 5, 2020 and compared with the data published in the literature. Thirty of the patients were male and twenty-six were female. Mean age was 41.3, average height was 163.5 cm and mean weight was 70.4 kg. Mean body mass index was 25.8. Twenty five patients had a chronic disease and twenty two patients were smokers. The most common clinical symptoms were fever (62.5%), cough (41.1%) and shortness of breath (21.4%). There were no active complaints in twenty four of the patients. Radiologically, nineteen patients had multifocal ground-glass opacity. The most prevalent laboratory findings were lymphopenia (30.3%), CRP elevation (62.5%) and AST elevation (42.8%). The findings of twenty three patients were normal. Forty seven patients were Rh positive, and nine patients were Rh negative. The Covid-19 epidemic continues with its global effects and affect people at various degrees. There are no clear clinical results and treatment options yet. Therefore, larger studies are needed.

PDF

___

1. Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle. J M Virol. 2020;92:401-2.

2. Hui DS, E IA, Madani TA, et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infecti Dis : IJID : official publication of the Int Soc Infect Dis. 2020;91:264-6.

3. Clinical management of severe acute respiratory infection when COVID-19 is suspected. WHO, 2020. (Accessed March 13, 2020, at https://www.who.int/ publications-detail/clinical-management-of-severe-acute-respiratory-infectionwhen-novel-coronavirus-(ncov)-infection-is-suspected.)

4. Drosten C, Gunther S, Preiser W, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. New England J Med. 2003;348:1967-76.

5. Zhu N, Zhang D, Wang W, et al. A Novel coronavirus from patients with pneumonia in China, 2019. New England J Med. 2020;382:727-33.

6. van Doremalen N, Bushmaker T, Morris DH, et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. New England J Med. 2020;382:1564-7.

7. Liu Y, Yan LM, Wan L, et al. Viral dynamics in mild and severe cases of COVID-19. The Lancet Infectious diseases 2020.

8. Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. New England J Med. 2020.

9. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet (London, England). 2020;395:1054-62.

10. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel Coronavirus–Infected pneumonia in Wuhan, China. JAMA. 2020;323:1061-9.

11. Wu Z, McGoogan JM. Characteristics of and important lessons from the Coronavirus Disease 2019 (COVID-19). outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323:1239-42.

12. Report of the WHO-China joint mission on Coronavirus disease 2019 (COVID-19) WHO, 2020. (Accessed May 20, 2020, at https://www.who.int/ docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-finalreport.pdf.).

13. Guan W-j, Ni Z-y, Hu Y, et al. Clinical characteristics of Coronavirus Disease 2019 in China. New England J Med. 2020;382:1708-20.

14. Verity R, Okell LC, Dorigatti I, et al. Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis.

15. Bajema KL, Oster AM, McGovern OL, et al. Persons Evaluated for 2019 Novel Coronavirus - United States, January 2020. MMWR Morbidity and mortality weekly report. 2020;69:166-70.

16. Wu D, Wu T, Liu Q, et al. The SARS-CoV-2 outbreak: What we know. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2020;94:44-8.

17. Mizumoto K, Kagaya K, Zarebski A, et al. Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin. 2020;25.

18. Giacomelli A, Pezzati L, Conti F, et al. Self-reported olfactory and taste disorders in SARS-CoV-2 patients: a cross-sectional study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2020.

19. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet (London, England). 2020;395:497- 506.

20. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet (London, England). 2020;395:507-13.

21. Zhao W, Zhong Z, Xie X, et al. Relation between chest CT findings and clinical conditions of Coronavirus disease (COVID-19). Pneumonia: a multicenter study. AJR Americ J Roentgen. 2020;214:1072-7.

22. Bai HX, Hsieh B, Xiong Z, et al. Performance of radiologists in differentiating COVID-19 from viral pneumonia on chest CT. Radiol. 2020:200823.

23. Li Z, Yi Y, Luo X, et al. Development and clinical application of a rapid IgMIgG combined antibody test for SARS-CoV-2 infection diagnosis. J Med Virol. 2020.

24. Bouadma L, Lescure FX, Lucet JC, et al. Severe SARS-CoV-2 infections: practical considerations and management strategy for intensivists. Intens Care Med. 2020;46:579-82.